Loading provider…
Loading provider…
Hematology & Oncology Physician in Louisville, KY
NPI: 1164440962Primary Practice Location
SCHNECK MEDICAL CENTER
411 W Tipton St, Seymour, IN
Primary Employer
Veterans Administration Medical Center
va.gov
HQ Phone
Get MD Naveed's Phone Numberphone_androidMobile
Get MD Naveed's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIN State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 636 | 2,377 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 432 | 695 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 269 | 317 |
| 4 | 80053Blood test, comprehensive group of blood chemicals | 161 | 619 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 152 | 874 |
Authors: Nathan Pennell, Heather Wakelee, Primo Lara, John Choe, Shirish Gadgeel, Thomas Lynch
Journal: J Thorac Oncol
Authors: David Berz, Mohammad Jahanzeb, Ajit Maniam, Lyudmila Bazhenova, Petros Nikolinakos, David Camidge, Nehal Masood
Journal: J Thorac Oncol
Publication Date: 2020-09-09
Lead Sponsor: Sermonix Pharmaceuticals Inc.
Collaborators: Linical Accelovance Group
Intervention / Treatment: DRUG: Fulvestrant, DRUG: Lasofoxifene
Lead Sponsor: Novartis Pharmaceuticals
Collaborators: Translational Research in Oncology
Intervention / Treatment: DRUG: Ribociclib, OTHER: Endocrine Therapy
Lead Sponsor: Pfizer
Collaborators: Merck KGaA, Darmstadt, Germany, Ono Pharmaceutical Co. Ltd, Pierre Fabre Medicament
Intervention / Treatment: DRUG: Cetuximab, DRUG: Irinotecan, DRUG: Encorafenib, DRUG: 5-Fluorouracil, DRUG: Folinic Acid, DRUG: Binimetinib